Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing
about
Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosisCaragaphenol a induces reactive oxygen species related apoptosis in human gastric cancer cells.CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line.CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line.YM155 enhances docetaxel efficacy in ovarian cancer.
P2860
Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing
@en
Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing.
@nl
type
label
Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing
@en
Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing.
@nl
prefLabel
Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing
@en
Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing.
@nl
P2093
P2860
P1476
Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing
@en
P2093
Di-Wei Zheng
Jia-Rong Huang
Jian-Ge Qiu
Jin-Ming Di
Meng-Ning Wei
Qi-Wei Jiang
Wen-Ji Zhang
P2860
P304
P407
P577
2016-09-15T00:00:00Z